Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study

AIMS: The aim of this study was to compare the risk of stroke or systemic embolism (SE) and major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and apixaban in routine clinical practice. METHODS AND RESULTS: Using nationwide registries in Norway from January 2013...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutherford, Ole-Christian W, Jonasson, Christian, Ghanima, Waleed, Söderdahl, Fabian, Halvorsen, Sigrun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073510/
https://www.ncbi.nlm.nih.gov/pubmed/31942972
http://dx.doi.org/10.1093/ehjcvp/pvz086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073510/
https://www.ncbi.nlm.nih.gov/pubmed/31942972
http://dx.doi.org/10.1093/ehjcvp/pvz086

Ejemplares similares